Abstract
THE diverse physiological actions of dopamine are mediated by its interaction with two basic types of G protein-coupled receptor, D1 and D2, which stimulate and inhibit, respectively, the enzyme adenylyl cyclase1. Alterations in the number or activity of these receptors may be a contributory factor in diseases such as Parkinson's disease and schizophrenia. Here we describe the isolation and characterization of the gene encoding a human D1 dopamine receptor. The coding region of this gene is intronless, unlike the gene encoding the D2 dopamine receptor. The D1 receptor gene encodes a protein of 446 amino acids having a predicted relative molecular mass of 49,300 and a transmembrane topology similar to that of other G protein-coupled receptors. Transient or stable expression of the cloned gene in host cells established specific ligand binding and functional activity characteristic of a D1 dopamine receptor coupled to stimulation of adenylyl cyclase. Northern blot analysis and in situ hybridization revealed that the messenger RNA for this receptor is most abundant in caudate, nucleus accumbens and olfactory tubercle, with little or no mRNA detectable in substantia nigra, liver, kidney, or heart. Several observations from this work in conjunction with results from other studies are consistent with the idea that other D1 dopamine receptor subtypes may exist.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kebabian, J. & Calne, D. Nature 277, 93â96 (1979).
Bunzow, J. et al. Nature 336, 783â787 (1988).
Ehinger, B. Prog. Retinal Res. 2, 213â232 (1983).
Gredal, O., Parkinson, D. & Nielsen, M. Eur. J. Pharmacol. 137, 241â245 (1987).
McGonigle, P., Wax, M. & Molinoff, P. Invest. Ophthalmol. Vis. Sci. 29, 687â694 (1988).
Andersson, S., Davis, D., Dahlback, H., Jornvall, H. & Russell, D. J. biol. Chem. 264, 8222â8229 (1989).
Sidhu, A., van Oene, J., Dandridge, P., Kaiser, C. & Kebabian, J. Eur. J. Pharmacol. 128, 213â220 (1986).
Billard, W., Ruperto, V., Crosby, G., Iorio, L. & Barnett, A. Life Sci. 35, 1885â1893 (1984).
Andersen, P., Gronwald, F. & Jansen, A. Life Sci. 37, 1971â1983 (1985).
Cotecchia, S. et al. Proc. natn. Acad. Sci. U.S.A. 85, 7159â7163 (1988).
Dixon, R. et al. Nature 326, 73â77 (1987).
Strader, C., Candelore, M., Hill, W., Sigal, I. & Dixon, R. J. biol. Chem. 264, 13572â13578 (1989).
O'Dowd, B. et al. J. biol. Chem. 263, 15985â15992 (1988).
Hubbard, S. & Ivatt, R. A. Rev. Biochem. 50, 555â583 (1981).
O'Dowd, B., Hnatowich, M., Caron, M. G., Lefkowitz, R. J. & Bouvier, M. J. biol. Chem. 264, 7564â7569 (1989).
Ovchinnikov, Y., Abdulaev, N. & Bogachuk, A. FEBS Lett. 230, 1â5 (1988).
Caron, M. et al. in G Proteins 295â316 (Academic, Orlando, Florida, 1990).
Wang, A., Doyle, M. & Mark, D. Proc. natn. Acad. Sci. U.S.A. 86, 9717â9721 (1989).
Dawson, T., Barone, P., Sidhu, A., Wamsley, J. & Chase, T. Neuroscience 26, 83â100 (1988).
Felder, C., Jose, P. & Axelrod, J. J. Pharmac. exp. Ther. 248, 171â175 (1989).
Sandrini, M., Benelli, A. & Baraldi, M. Life Sci. 35, 1839â1849 (1984).
Meador-Woodruff, J. et al. Proc. natn. Acad. Sci. U.S.A. 86, 7625â7628 (1989).
Spano, P., Trabucchi, M. & Di Chiana, G. Science 196, 1343â1345 (1977).
Creese, I., Morrow, L., Leff, S., Sibley, D. & Hamblin, M. Int. Rev. Neurobiol. 23, 255â301 (1982).
Niznik, H. Molec. cell Endocrinol. 54, 1â22 (1987).
Schofield, P., Shivers, B. & Seeburg, P. Trends Neurosci. 13, 8â11 (1990).
Andersen, P. et al. Trends Pharmacol. Sci. 11, 231â236 (1990).
Undie, A. & Friedman, E. Ninth Int. Washington Spring Symp.Biol. Cell. Transducing Signals 261 (1989).
Mahan, L., Burch, R., Monsma, F. & Sibley, D. Proc. natn. Acad. Sci. U.S.A. 87, 2196â2200 (1990).
Felder, R., Blecher, M., Calcagno, P. & Jose, P. Am. J. Physiol. 247, F499âF505 (1984).
Felder, C., Blecher, M. & Jose, P. J. biol. Chem. 264, 8739â8745 (1989).
DeLean, A., Hancock, A. & Lefkowitz, R. Molec. Pharmcol. 21, 5â16 (1982).
Kozak, M. Nucleic Acids Res. 12, 857â872 (1984).
Cullen, B. Meth. Enzym. 152, 684â704 (1987).
Salomon, Y., Londos, C. & Rodbell, M. Analyt. Biochem. 58, 541â548 (1974).
Bouvier, M. et al. Molec. Pharmacol. 33, 133â139 (1988).
Chirgwin, J., Przybyla, A., MacDonald, R. & Rutter, W. Biochemistry 18, 5294â5299 (1979).
Sambrook, J., Fritsch, E. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory, New York, 1989).
Fremeau, R. Jr, Lundblad, J., Pritchett, D., Wilcox, J. & Roberts, J. Science 234, 1265â1269 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dearry, A., Gingrich, J., Falardeau, P. et al. Molecular cloning and expression of the gene for a human D1 dopamine receptor . Nature 347, 72â76 (1990). https://doi.org/10.1038/347072a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/347072a0
This article is cited by
-
Neuropeptides Modulate Feeding via the Dopamine Reward Pathway
Neurochemical Research (2023)
-
OZITX, a pertussis toxin-like protein for occluding inhibitory G protein signalling including Gαz
Communications Biology (2022)
-
Glycoconjugate journal special issue on: the glycobiology of Parkinsonâs disease
Glycoconjugate Journal (2022)
-
Dopamine and addiction: what have we learned from 40Â years of research
Journal of Neural Transmission (2019)
-
Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe
Clinical Drug Investigation (2016)